Financhill
Back

Protagonist Therapeutics Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
45

PTGX
Protagonist Therapeutics

Last Price:
43.12
Seasonality Move:
12.96%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Protagonist Therapeutics Stock Forecast

  • Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 40.7% based on the past 8 years of stock performance.
  • Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
  • Is Protagonist Therapeutics Stock Undervalued?
    The current Protagonist Therapeutics [PTGX] share price is $46.50. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Protagonist Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 40.7% based on the past 8 years of stock performance.

Protagonist Therapeutics Stock Rating

Sell
45
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics overpriced?

  • Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%

Protagonist Therapeutics Stock Price History

Is PTGX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com

52-Week Data

52-Week High:
48.89
52-Week Low:
15.05

Prediction Charts

Market Cap:
2.77B
Price in USD:
46.50
Volume:
558.13K
Beta:
2.10

Technical Analysis

SMA50:
45.52
SMA100:
41.49
SMA200:
35.08
52-Wk Change:
200.19%

Stock Predictions

  • Is Protagonist Therapeutics stock public?
    Yes, Protagonist Therapeutics is a publicly traded company.
  • What is the Protagonist Therapeutics stock quote today?
    The Protagonist Therapeutics stock price is 46.50 USD today.
  • How to buy Protagonist Therapeutics stock online?
    You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 46.31 46.59 46.68 45.48
Oct-24 46.71 46.95 47.30 46.34
Oct-25 47.30 47.26 47.95 46.84
Oct-28 47.69 48.20 48.89 47.35
Oct-29 47.95 48.42 48.62 47.58
Oct-30 48.01 47.62 48.30 47.44
Oct-31 47.18 45.83 47.32 45.65
Nov-1 46.11 46.76 47.02 45.99
Nov-4 46.30 46.76 47.76 45.37
Nov-5 47.15 45.90 47.31 43.86
Nov-6 48.16 47.57 48.67 46.39
Nov-7 47.43 47.61 48.69 46.53
Nov-8 48.86 46.23 48.86 45.23
Nov-11 46.90 46.50 48.35 46.43

Protagonist Therapeutics Earnings

Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Protagonist Therapeutics Forecast Revenue Growth

Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.24 per share, and a decrease next year of $5.00 per share.

* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.